scholarly journals Novel Lipidated Imidazoquinoline TLR7/8 Adjuvants Elicit Influenza-Specific Th1 Immune Responses and Protect Against Heterologous H3N2 Influenza Challenge in Mice

2020 ◽  
Vol 11 ◽  
Author(s):  
Shannon M. Miller ◽  
Van Cybulski ◽  
Margaret Whitacre ◽  
Laura S. Bess ◽  
Mark T. Livesay ◽  
...  
2021 ◽  
Vol 11 (1) ◽  
Author(s):  
James D. Allen ◽  
Ted M. Ross

AbstractWhile vaccines remain the best tool for preventing influenza virus infections, they have demonstrated low to moderate effectiveness in recent years. Seasonal influenza vaccines typically consist of wild-type influenza A and B viruses that are limited in their ability to elicit protective immune responses against co-circulating influenza virus variant strains. Improved influenza virus vaccines need to elicit protective immune responses against multiple influenza virus drift variants within each season. Broadly reactive vaccine candidates potentially provide a solution to this problem, but their efficacy may begin to wane as influenza viruses naturally mutate through processes that mediates drift. Thus, it is necessary to develop a method that commercial vaccine manufacturers can use to update broadly reactive vaccine antigens to better protect against future and currently circulating viral variants. Building upon the COBRA technology, nine next-generation H3N2 influenza hemagglutinin (HA) vaccines were designed using a next generation algorithm and design methodology. These next-generation broadly reactive COBRA H3 HA vaccines were superior to wild-type HA vaccines at eliciting antibodies with high HAI activity against a panel of historical and co-circulating H3N2 influenza viruses isolated over the last 15 years, as well as the ability to neutralize future emerging H3N2 isolates.


2001 ◽  
Vol 22 (5) ◽  
pp. 244-247 ◽  
Author(s):  
Thomas T MacDonald ◽  
Giovanni Monteleone

2012 ◽  
Vol 209 (8) ◽  
pp. 1437-1444 ◽  
Author(s):  
R. William DePaolo ◽  
Karishma Kamdar ◽  
Samira Khakpour ◽  
Yui Sugiura ◽  
Wenxia Wang ◽  
...  

The balance between regulatory and inflammatory immune responses is critical to maintain intestinal homeostasis. Furthermore, the nature of the inflammatory response needs to be tailored to the tissue to provide proper protective immunity while preserving host integrity. TLR2 (Toll-like receptor 2) is a unique TLR in that it has been shown to promote regulatory and inflammatory T cell responses. Using Yersinia enterocolitica, we show that oral infection promotes TH17 immunity, whereas systemic infection promotes TH1 immunity. Furthermore, induction of TH17 immunity during oral infection is dependent on TLR1 and results from the combinatorial effect of TLR2/TLR1-induced IL-6 and IL-23 and the presence of TGF-β in the intestinal environment. Interestingly, TLR2/TLR1 was not involved in TH1 immune responses during systemic infection, whereas the TLR2/TLR6 receptor complex induced IL-10+ regulatory T cell responses during both systemic and oral infections. Our results reveal that the route of infection is central in determining which pathways provide protective immunity. Furthermore, they also demonstrate that TLR2 has dual immune functions in the gut and identify TLR1 as a critical innate receptor for protective intestinal TH17 immunity.


2014 ◽  
Vol 60 (1) ◽  
pp. S171
Author(s):  
L.J. Blackmore ◽  
J.M. Ryan ◽  
X. Huang ◽  
M. Hussain ◽  
E. Triantafyllou ◽  
...  

2013 ◽  
Vol 35 (3) ◽  
pp. 329-335 ◽  
Author(s):  
Mi Eun Kim ◽  
Hyung Keun Kim ◽  
Dong Hwan Kim ◽  
Ju Hwa Yoon ◽  
Jun Sik Lee

Vaccine ◽  
2011 ◽  
Vol 29 (15) ◽  
pp. 2742-2748 ◽  
Author(s):  
Feng Tan ◽  
Xin Hu ◽  
Fang-Jun Luo ◽  
Chang-Wang Pan ◽  
Xiao-Guang Chen

2003 ◽  
Vol 170 (9) ◽  
pp. 4457-4464 ◽  
Author(s):  
Ingrid L. Dodge ◽  
Michelle Woldemar Carr ◽  
Manuela Cernadas ◽  
Michael B. Brenner

Blood ◽  
2005 ◽  
Vol 105 (3) ◽  
pp. 1016-1020 ◽  
Author(s):  
Tatsuki R. Kataoka ◽  
Nobuyasu Komazawa ◽  
Eiichi Morii ◽  
Keisuke Oboki ◽  
Toru Nakano

Abstract Mast cells are the sentinels of immune systems and, like other immuno-competent cells, they are produced by hematopoietic stem cells. We analyzed the expression of signal transducer and activator of transcription 4 (Stat4), and investigated its role in mast cells. Murine mast cells are usually divided into 2 distinct populations by their distribution and contents of their granules: mucosal mast cells (MMCs) and connective tissue–type mast cells (CTMCs). Stat4 protein was detected in CTMCs but not in MMCs. The absence of Stat4 expression in cultured mast cells was due to the presence of Stat6. In T-helper (Th) cells, Stat4 plays an important role in Th1 shift by inducing a set of genes, such as interferon gamma (IFN-γ) and interleukin-18 receptor α subunit (IL-18Rα). As in Th1 shift, we found that Stat4 trans-activated these genes in the Stat4-expressing cultured mast cells, namely, microphthalmia transcription factor (MITF)–deficient cultured MMCs, Stat6-deficient cultured MMCs, and cultured CTMCs. Stat4 also enhanced expression of nitric oxide synthase 2 (NOS2) in CTMCs, which brought about increased levels of NO-dependent cytotoxic activity. These data indicate that expression of Stat4 in CTMCs plays an important role on Th1 immune responses.


Sign in / Sign up

Export Citation Format

Share Document